IART logo

IART Operating Expenses

Annual Operating Expenses

$773.21 M
+$41.82 M+5.72%

December 31, 2023

Summary

Performance

1-Year Change

+5.72%

3-Year Change

+10.51%

5-Year Change

-2.12%

15-Year Change

+9.22%

IART Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

89.38%
IART annual total operating expenses is higher than 89.38% of companies in Healthcare sector

High & Low

All-time High

$794.20 M
IART annual total operating expenses is currently -2.64% below its historical high of $794.20 million

3-Year Low

$731.39 M
IART annual total operating expenses is currently +5.72% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
IART previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
IART next annual earnings announcement has not yet been scheduled

OtherIARTexpensesmetrics:

Annual Total Expenses

$1.43 B
IART annual total expenses is $1.43 billion

Annual Interest Expense

$51.38 M
IART annual interest expense is $51.38 million

Annual Income Tax

$13.33 M
IART annual income tax is $13.33 million

Annual Cost Of Goods Sold

$656.84 M
IART annual cost of goods sold is $656.84 million

Quarterly Operating Expenses

$208.39 M
-$20.56 M-8.98%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+8.68%

3-Year Change

+8.68%

5-Year Change

+8.68%

IART Quarterly Operating Expenses Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

89.46%
IART quarterly total operating expenses is higher than 89.46% of companies in Healthcare sector

High & Low

All-time High

$228.95 M
IART quarterly total operating expenses is currently -8.98% below its historical high of $228.95 million

3-Year Low

$171.70 M
IART quarterly total operating expenses is currently +21.37% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
IART previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

N/A
IART next earnings announcement has not yet been scheduled

OtherIARTexpensesmetrics:

Quarterly Total Expenses

$388.98 M
IART quarterly total expenses is $388.98 million

Quarterly Interest Expense

$19.37 M
IART quarterly interest expense is $19.37 million

Quarterly Income Tax

-$9.67 M
IART quarterly income tax is -$9.67 million

Quarterly Cost Of Goods Sold

$180.60 M
IART quarterly cost of goods sold is $180.60 million

Operating Expenses Formula

Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses

Annual Operating Expenses

$773.21 M
IART annual total operating expenses is $773.21 million

Annual SGA

$656.64 M
IART annual SGA is $656.64 million

Annual D&A

$123.51 M
IART annual depreciation & amortization is $123.51 million

IART Operating Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+5.7%+8.7%
3 y3 years+10.5%+8.7%
5 y5 years-2.1%+8.7%

IART Operating Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+5.7%-9.0%+21.4%
5 y5-year-2.6%+10.5%-9.0%+49.8%
alltimeall time-2.6%+5988.3%-9.0%+5853.9%

Integra LifeSciences Holdings Operating Expenses History

DateAnnualQuarterly
Sep 2024
-
$208.39 M(-9.0%)
Jun 2024
-
$228.95 M(+12.9%)
Mar 2024
-
$202.87 M(+6.5%)
Dec 2023
$773.21 M(+5.7%)
$190.45 M(-0.7%)
Sep 2023
-
$191.75 M(-1.4%)
Jun 2023
-
$194.52 M(-1.0%)
Mar 2023
-
$196.49 M(+7.8%)
Dec 2022
$731.39 M(-2.1%)
$182.25 M(+6.1%)
Sep 2022
-
$171.70 M(-9.4%)
Jun 2022
-
$189.54 M(+0.9%)
Mar 2022
-
$187.91 M(-1.6%)
Dec 2021
$747.41 M(+6.8%)
$191.05 M(+2.7%)
Sep 2021
-
$185.95 M(-0.5%)
Jun 2021
-
$186.87 M(+1.8%)
Mar 2021
-
$183.53 M(-2.9%)
Dec 2020
$699.66 M(-11.9%)
$188.93 M(+6.2%)
Sep 2020
-
$177.88 M(+27.9%)
Jun 2020
-
$139.11 M(-28.2%)
Mar 2020
-
$193.75 M(-5.3%)
Dec 2019
$794.20 M(+0.5%)
$204.56 M(+3.8%)
Sep 2019
-
$197.16 M(+1.6%)
Jun 2019
-
$194.01 M(-2.2%)
Mar 2019
-
$198.47 M(-2.1%)
Dec 2018
$789.95 M(+11.6%)
$202.74 M(+1.9%)
Sep 2018
-
$198.93 M(-1.0%)
Jun 2018
-
$200.99 M(+7.3%)
Mar 2018
-
$187.28 M(-12.2%)
Dec 2017
$707.92 M(+34.2%)
$213.21 M(+28.1%)
Sep 2017
-
$166.44 M(+0.2%)
Jun 2017
-
$166.18 M(+2.5%)
Mar 2017
-
$162.09 M(+25.2%)
Dec 2016
$527.65 M(+10.7%)
$129.47 M(-1.1%)
Sep 2016
-
$130.91 M(-4.7%)
Jun 2016
-
$137.37 M(+5.8%)
Mar 2016
-
$129.90 M(+2.2%)
Dec 2015
$476.61 M(+11.9%)
$127.15 M(-2.4%)
Sep 2015
-
$130.30 M(+15.2%)
Jun 2015
-
$113.08 M(+6.6%)
Mar 2015
-
$106.07 M(+1.5%)
Dec 2014
$425.91 M(+11.5%)
$104.47 M(-1.9%)
Sep 2014
-
$106.52 M(-19.3%)
Jun 2014
-
$131.98 M(+6.5%)
Mar 2014
-
$123.94 M(+332.8%)
Dec 2013
$381.91 M(-13.7%)
$28.64 M(-75.3%)
Sep 2013
-
$115.88 M(-1.9%)
Jun 2013
-
$118.16 M(-0.9%)
Mar 2013
-
$119.23 M(+4.6%)
Dec 2012
$442.66 M(+3.9%)
$113.94 M(+2.8%)
Sep 2012
-
$110.80 M(-2.7%)
Jun 2012
-
$113.88 M(+9.4%)
Mar 2012
-
$104.04 M(-8.0%)
Dec 2011
$426.02 M(+16.7%)
$113.03 M(+7.4%)
Sep 2011
-
$105.24 M(-6.4%)
Jun 2011
-
$112.49 M(+18.1%)
Mar 2011
-
$95.25 M(-3.5%)
Dec 2010
$365.19 M
$98.67 M(+9.5%)
Sep 2010
-
$90.14 M(+0.7%)
Jun 2010
-
$89.55 M(+3.1%)
DateAnnualQuarterly
Mar 2010
-
$86.83 M(-5.3%)
Dec 2009
$339.75 M(-4.1%)
$91.73 M(+7.4%)
Sep 2009
-
$85.44 M(+4.2%)
Jun 2009
-
$82.02 M(+1.8%)
Mar 2009
-
$80.55 M(-0.9%)
Dec 2008
$354.37 M(+32.0%)
$81.26 M(-35.3%)
Sep 2008
-
$125.60 M(+69.2%)
Jun 2008
-
$74.24 M(+1.3%)
Mar 2008
-
$73.26 M(-8.0%)
Dec 2007
$268.50 M(+39.7%)
$79.67 M(+21.0%)
Sep 2007
-
$65.82 M(+1.2%)
Jun 2007
-
$65.06 M(+12.3%)
Mar 2007
-
$57.95 M(+7.7%)
Dec 2006
$192.24 M(+65.3%)
$53.80 M(-6.1%)
Sep 2006
-
$57.27 M(+25.6%)
Jun 2006
-
$45.59 M(+28.2%)
Mar 2006
-
$35.57 M(+14.9%)
Dec 2005
$116.29 M(-1.2%)
$30.96 M(+15.3%)
Sep 2005
-
$26.85 M(-10.9%)
Jun 2005
-
$30.12 M(+6.1%)
Mar 2005
-
$28.39 M(+13.7%)
Dec 2004
$117.75 M(+56.3%)
$24.96 M(-49.0%)
Sep 2004
-
$48.90 M(+111.0%)
Jun 2004
-
$23.18 M(+11.9%)
Mar 2004
-
$20.71 M(-17.5%)
Dec 2003
$75.36 M(+66.2%)
$25.09 M(+45.3%)
Sep 2003
-
$17.27 M(-0.5%)
Jun 2003
-
$17.36 M(+11.0%)
Mar 2003
-
$15.64 M(+71.6%)
Dec 2002
$45.34 M(+21.3%)
$9.11 M(-33.4%)
Sep 2002
-
$13.68 M(+19.1%)
Jun 2002
-
$11.49 M(+3.8%)
Mar 2002
-
$11.06 M(+22.5%)
Dec 2001
$37.39 M(-33.9%)
$9.03 M(-4.2%)
Sep 2001
-
$9.43 M(-2.0%)
Jun 2001
-
$9.62 M(-10.2%)
Mar 2001
-
$10.71 M(-58.2%)
Dec 2000
$56.55 M(+63.8%)
$25.60 M(+141.0%)
Sep 2000
-
$10.62 M(+15.4%)
Jun 2000
-
$9.20 M(+1.5%)
Mar 2000
-
$9.07 M(+16.0%)
Dec 1999
$34.52 M(+37.7%)
$7.82 M(-10.1%)
Sep 1999
-
$8.70 M(-7.4%)
Jun 1999
-
$9.40 M(+54.1%)
Mar 1999
-
$6.10 M(+9.5%)
Dec 1998
$25.07 M(-10.1%)
$5.57 M(-5.6%)
Sep 1998
-
$5.90 M(-10.6%)
Jun 1998
-
$6.60 M(-7.0%)
Mar 1998
-
$7.10 M(-44.1%)
Dec 1997
$27.90 M(+55.9%)
$12.70 M(+126.8%)
Sep 1997
-
$5.60 M(+9.8%)
Jun 1997
-
$5.10 M(+15.9%)
Mar 1997
-
$4.40 M(-4.3%)
Dec 1996
$17.90 M(+40.9%)
$4.60 M(+2.2%)
Sep 1996
-
$4.50 M(-6.3%)
Jun 1996
-
$4.80 M(+23.1%)
Mar 1996
-
$3.90 M(0.0%)
Dec 1995
$12.70 M
$3.90 M(+11.4%)
Sep 1995
-
$3.50 M

FAQ

  • What is Integra LifeSciences Holdings annual total operating expenses?
  • What is the all time high annual operating expenses for Integra LifeSciences Holdings?
  • What is Integra LifeSciences Holdings annual operating expenses year-on-year change?
  • What is Integra LifeSciences Holdings quarterly total operating expenses?
  • What is the all time high quarterly operating expenses for Integra LifeSciences Holdings?
  • What is Integra LifeSciences Holdings quarterly operating expenses year-on-year change?

What is Integra LifeSciences Holdings annual total operating expenses?

The current annual operating expenses of IART is $773.21 M

What is the all time high annual operating expenses for Integra LifeSciences Holdings?

Integra LifeSciences Holdings all-time high annual total operating expenses is $794.20 M

What is Integra LifeSciences Holdings annual operating expenses year-on-year change?

Over the past year, IART annual total operating expenses has changed by +$41.82 M (+5.72%)

What is Integra LifeSciences Holdings quarterly total operating expenses?

The current quarterly operating expenses of IART is $208.39 M

What is the all time high quarterly operating expenses for Integra LifeSciences Holdings?

Integra LifeSciences Holdings all-time high quarterly total operating expenses is $228.95 M

What is Integra LifeSciences Holdings quarterly operating expenses year-on-year change?

Over the past year, IART quarterly total operating expenses has changed by +$16.64 M (+8.68%)